Medical Humidifier Market by Product (Heated, Heat & Moisture Exchangers, Humidifier Accessories), Application (ICUs , Neonatal Care),Distribution Channel (Online), Patient Type (Adult), End user (Hospitals) and Region – Global Forecast to 2029
The global medical humidifier market, valued at US$878.4 million in 2023, stood at US$922.8 million in 2024 and is projected to advance at a resilient CAGR of 5.6% from 2024 to 2029, culminating in a forecasted valuation of US$1,211.7 million by the end of the period. Increased admissions to intensive care (ICUs) and neonatal intensive care units (NICUs), especially for ventilator-dependent patients, increasing neonatal mortality & preterm birth rates, aging populations, and rising healthcare costs are shifting patient care from hospitals to home settings. Governments and private investors are expanding hospital networks, leading to higher demand for humidification devices, which drives market growth. Additionally, government and non-government initiatives in respiratory health and post-pandemic demand for respiratory care also offer opportunities for market growth.
Download PDF Brochure
By product, heat and moisture exchangers (HMEs) segment to grow at the fastest rate in the Medical humidifier market across the forecast period.
Based on product, the Medical humidifier market is segmented into Heated Humidifier, Bubble Humidifier, Heat and Moisture Exchangers (HMEs), and Humidifier Accessories. Among theses, in 2023, Heat and Moisture Exchangers (HMEs) segment accounts for the highest growth rate in the Medical humidifier market. This is due to increasing surgical volumes worldwide, especially in developed and emerging economies, is fueling demand for anesthesia-related humidification devices, compared to active humidification systems, HMEs are more affordable, require no power source, and have low maintenance costs, HMEs enhance comfort for patients using CPAP and BiPAP machines for sleep apnea and chronic respiratory conditions, and growing healthcare access in Asia Pacific, Latin America, and the Middle East is driving the uptake of HMEs in newly built hospitals and homecare settings.
By patient type, adult patients holds the largest share in the Medical humidifier market in 2023.
The medical humidifier market is divided into three segments based on patient type: adult, pediatric, and neonatal.
Among them, in 2023, adult patients segment accounts for the greatest market share of the medical humidifier market, since age-related loss of lung function necessitates the use of humidifiers in long-term oxygen treatment (LTOT), CPAP/BiPAP therapy, and home ventilation. Postoperative ventilation in adults undergoing surgeries (cardiac, neurological, and pulmonary) drives demand for heated humidifiers and heat moisture exchangers (HMEs), as does the growing elderly population (65 and older), who are more susceptible to chronic respiratory failure and pulmonary infections. According to the World Health Organization (2024), by 2030, one in every six individuals worldwide would be 60 or older, with the population in this age group expected to increase from 1 billion in 2020 to 1.4 billion. Furthermore, the number of people aged 80 and older is expected to triple between 2020 and 2025, reaching 424 million. The medical humidifier market is predicted to grow in line with the large growth in the aging population, especially among the elderly.
North America dominates the global Medical humidifier market in 2023.
The medical humidifier market is segmented into six major regional segments, namely, North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries. The north America accounts for the largest market share in the medical humidifier market in 2023. This is due to rising ICU admissions and ventilator use, which necessitate humidification systems for oxygen therapy and mechanical ventilation, ongoing development and commercialization of medical humidifier products, supportive government regulations for product commercialization, and significant investments in hospital infrastructure. For example, the World Bank Group predicts that in 2022, North America’s health expenditure will account for 16.6% of the region’s GDP, indicating a high commitment to healthcare infrastructure development. Additionally, the huge presence of medical humidifier manufacturing companies in the region is increasing the market growth in the region. These companies are investing heavily in research and developments thus providing technologically advanced medical humidifiers across the region thus contributing to the regional growth.
Key Players
Prominent players in the Medical humidifier market include, include ResMed Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Fisher & Paykel Healthcare Limited (New Zealand), Koninklijke Philips N.V. (Netherlands), Vincent Medical Holdings Limited (Hong Kong), Medline Industries, LP. (US), Hamilton Medical (Switzerland), GaleMed Corporation (Taiwan), and Eakin Healthcare (UK).
Request Sample Pages
MARKET DYNAMICS
DRIVERS
– Rising use of medical humidifiers in ventilation therapy
– Increasing prevalence of respiratory diseases
– Rising incidence of premature births and advances in neonatal care
– Rapid growth in geriatric population
RESTRAINTS
– Frequent replacement of disposable components, increasing operational costs
– Low awareness of threat of respiratory diseases
OPPORTUNITIES
– Post-pandemic demand for respiratory care
– Government and non-government initiatives in respiratory health
– Increasing investments in hospital infrastructure in emerging markets
CHALLENGES
– Risk of infections due to improper maintenance
– High cost of advanced humidifiers to limit adoption
Recent Developments of Medical Humidifier Market
* Product Launch: In August 2024, Fisher & Paykel Healthcare Limited (New Zealand) introduced the F&P My820, a new respiratory humidifier designed for home mechanical ventilation. It provides heated humidification for both invasive and non-invasive ventilation, as well as humidified high-flow therapy, to adult and pediatric patients. * Product Approval: GaleMed Corporation (Taiwan) was certified in Medical Device Regulation (MDR) for several respiratory care devices in June 2024. This certification guarantees adherence to EU regulatory criteria, strengthening the company’s dedication to patient safety and the quality of products. * Agreement: In March 2024, Medline Industries, LP (US) was chosen as the exclusive supplier of medical and surgical supplies for LVHN’s 13 acute care hospitals. The company announced a multi-year prime vendor distribution agreement with Lehigh Valley Health Network, a leading US health system providing care across 95 specialties at 13 hospital campuses in eastern Pennsylvania. * Agreement: In October 2024, Medline Industries, LP (US) announced a multi-year prime vendor distribution agreement with California-based Kaweah Health, a prominent community hospital. Under this agreement, Medline will be the exclusive medical and surgical supply provider to the healthcare organization.
News From
MarketsandMarkets™
Category: Industry Reports & Market Analysis Profile: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, w …
This email address is being protected from spambots. You need JavaScript enabled to view it.
